Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 USD | +1.54% | -9.55% | +7.57% |
May. 29 | HC Wainwright Starts Cognition Therapeutics With Buy Rating, $10 Price Target | MT |
May. 07 | Cognition Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.57% | 78.11M | |
+14.37% | 118B | |
+12.82% | 106B | |
-3.36% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-17.66% | 15.56B | |
+4.14% | 13.63B | |
+28.12% | 12.27B |
- Stock Market
- Equities
- CGTX Stock
- News Cognition Therapeutics, Inc.
- Oppenheimer Adjusts Cognition Therapeutics Price Target to $9 From $18, Maintains Outperform Rating